{"database": "lobbying", "table": "lobbying_activities", "rows": [[2976357, "dd2ef5d3-829f-4f42-a8c0-46958f744a7d", "Q1", "BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC", 292972, "BOEHRINGER INGELHEIM USA CORPORATION", 2023, "first_quarter", "ANI", "Issues related to Animal Health Issues related to Veterinary Telehealth Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418)", "Agriculture, Dept of (USDA),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,SENATE", null, 1420000, 0, 0, "2023-04-20T10:17:38-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2976357"], "units": {}, "query_ms": 15.227324096485972, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}